Public Access Records Office
The National Academies
500 5th Street NW
Room NAS 168
Washington, DC 20001
Tel: (202) 334-3543
FAX: (202) 334-2158
Email: paro@nas.edu
Project Information

Project Information


Review of the Health Effects in Vietnam Veterans of Exposure to Herbicides–Eleventh Biennial Update


Project Scope:

An ad hoc committee will conduct a study to “determine (to the extent that available scientific data permit meaningful determinations)” the following regarding associations between specific health outcomes and exposure to TCDD and other chemicals present in herbicides used by the military in Vietnam:

A.    whether a statistical association with herbicide exposure exists, taking into account the strength of the scientific evidence and the appropriateness of the statistical and epidemiological methods used to detect the association;

B.     the increased risk of disease among those exposed to herbicides during service in the Republic of Vietnam during the Vietnam era; and

C.     whether there exists a plausible biological mechanism or other evidence of a causal relationship between herbicide exposure and the disease. [P.L. 102-4, §3(d)]

It will also assess the current research available on possible generational health effects that may be the result of exposures to these chemicals—including the biologic plausibility or potential for an exposure to lead to an increased risk of birth defects or other adverse conditions in the descendants of male Veterans—and will address myeloproliferative neoplasms (MPN) as part of its consideration of the literature concerning leukemias and related diseases. The review of brain cancer will address, in particular, glioblastoma multiforme.  The report will offer findings, conclusions, and recommendations as appropriate.

Status: Current

PIN: HMD-BSP-16-03

Project Duration (months): 24 month(s)

RSO: Butler, David

Topic(s):

Health and Medicine


Committee Membership

Committee Post Date: 02/09/2017



Dr. Irva Hertz-Picciotto - (Chair)


Irva Hertz-Picciotto, M.P.H., Ph.D. is a professor in the Department of Public Health Sciences, School of Medicine, and at the Medical Investigations of Neurodevelopmental Disorders (MIND) Institute, University of California, Davis (UCD), and is chief of the Division of Environmental and Occupational Health. She currently directs the NIH-funded Environmental Health Sciences Center at UCD, along with the Program on Environmental Epidemiology of Autism and Neurodevelopment at the MIND. She has published over 250 scientific papers on environmental exposures, including metals, pesticides, PCBs, and air pollution, and their effects on pregnancy, the neonate, and early child development, as well as on methods in epidemiologic research. She has also led several cohort studies of toxic chemicals and both pregnancy outcomes and early child development internationally. Dr. Hertz-Picciotto has served on scientific advisory panels for the U.S. Environmental Protection Agency, the NIH National Toxicology Program, and the California Governor’s Proposition 65 committee. She has served or currently sits on editorial boards for the American Journal of Epidemiology, Environmental Health Perspectives, Epidemiology, and Autism Research. She served as president of the Society for Epidemiologic Research and of the International Society for Environmental Epidemiology, and in 2011 she received the Goldsmith Lifetime Achievement Award from the International Society for Environmental Epidemiology. Recently she co-founded Project TENDR (Targeting Environment and Neuro-Developmental Risks), a collaborative effort of scientists, clinicians, policy-makers and advocates that aims to decrease the incidence of neurodevelopmental disorders by reducing neurotoxicant exposures that contribute to them. Dr. Hertz-Picciotto has previously chaired three National Academies committees: one on breast cancer and the environment and two previous updates of Committees to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides. She received a Ph.D. and an M.P.H. in epidemiology and an M.A. in biostatistics from UC Berkeley. Before joining the faculty at UC Davis, Dr. Hertz-Picciotto was a professor in the Department of Epidemiology at the School of Public Health, University of North Carolina, Chapel Hill. She is a National Associate of the National Academies.
Dr. Michael J. Carvan, III


Michael J. Carvan, III, Ph.D., M.S., is a Shaw Professor at the School of Freshwater Sciences and School of Public Health, both of the University of Wisconsin-Milwaukee. He earned his M.S. in biologic oceanography at the University of Miami's Rosenstiel School of Marine and Atmospheric Science in Coral Gables and his Ph.D. in veterinary anatomy and public health with a focus in toxicology from Texas A&M University's College of Veterinary Medicine in College Station. After obtaining his doctorate, Dr. Carvan held National Institute of Environmental Health Sciences molecular toxicology fellowships at the University of Cincinnati Medical Center. His research uses zebrafish as a genetic system for identifying genes that influence susceptibility of response to xenobiotics. He has served on the National Academies of Sciences, Engineering, and Medicine (NASEM) Board on Life Sciences, and as a committee member on the ninth and tenth updates to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides.
Dr. Dana C. Dolinoy


Dana Dolinoy, Ph.D., is associate professor of environmental health sciences and nutritional sciences at the University of Michigan School of Public Health, and leads the Environmental Epigenetics and Nutrition Laboratory, which investigates how nutritional and environmental factors interact with epigenetic gene regulation to shape health and disease. She serves on the Editorial Boards of the Journal of Nutritional Biochemistry and Epigenetics and as an Associate Editor for Environmental Health Perspectives, Environmental Epigenetics, and Toxicological Sciences and is an active member of the Society of Toxicology, the Environmental Mutagen and Genomics Society, and the American Society for Nutrition, and served as Chair of the 2015 Gordon Research Conference in Molecular & Cellular Mechanisms of Toxicity. In 2012, she was the recipient of the Association of Schools of Public Health/Pfizer Research Award for the article "An Expression Microarray Approach for the Identification of Metastable Epialleles in the Mouse Genome," a work that has been cited as a model approach that may allow for directly assessing the role of early nutritional and environmental exposures in human adult disease. Dr. Dolinoy recently received the 2015 NIH Director’s Transformative Research Award to develop novel epigenome editing tools to reduce disease risk and in 2016 served as the Chair of the SOT Contemporary Concepts in Toxicology (CCT) meeting ToxicoEpigenetics: The Interface of Epigenetics and Risk Assessment. Dr. Dolinoy holds an M.Sc. in environmental sciences and engineering from the Harvard School of Public Health, and a Ph.D. in genetics and genomics and integrated toxicology from Duke University.
Dr. Mary A. Fox


Mary A. Fox, Ph.D., is assistant professor in the Department of Health Policy and Management and co-director of the Risk Sciences and Public Policy Institute at the Johns Hopkins Bloomberg School of Public Health. She teaches courses in quantitative risk assessment methods and risk policy and management for the Risk Sciences and Public Policy Institute’s Certificate Program. Dr. Fox’s research is focused on human health risk assessment as a part of environmental policy making, particularly approaches to cumulative and chemical mixtures risk assessment. Dr. Fox has served on three National Academies committees including the one responsible for the most recent Gulf War and Health report, Volume 10: Update of Health Effects of Serving in the Gulf War. She also served on committees that examined the long-term health consequences of exposure to burn pits in Iraq and Afghanistan, and the health risks of phthalate exposure. Dr. Fox began her public health career conducting community health studies around hazardous waste sites as a research scientist in the New York State Department of Health. She received her M.P.H. from the University of Rochester School of Medicine and Dentistry and Ph.D. from the Johns Hopkins Bloomberg School of Public Health.
Dr. Karl T. Kelsey


Karl T. Kelsey, M.D., M.O.H., is a professor of epidemiology, and pathology and laboratory medicine at Brown University. He is also the director of Center for Environmental Health and Technology. Until 2007, he was on the faculty of the Harvard School of Public Health and Harvard Medical School. He is interested in the application of laboratory-based biomarkers in chronic-disease epidemiology and tumor biology and in characterizing individual susceptibility to cancer. Dr. Kelsey is an author of more than 200 publications and has served on the National Academies’ committees on toxicity testing and assessment of environmental agents, copper in drinking water, the evaluation of the Department of Veterans Affairs Uniform Case Assessment Protocol to review the health consequences of service during the Persian Gulf War, curriculum development in environmental medicine, the health effects of mustard gas and lewisite, and most recently on the past three Committees to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides. Dr. Kelsey received his M.D. from the University of Minnesota and a master’s degree in occupational health from Harvard University.


Dr. Andrew F. Olshan


Andrew F. Olshan, Ph.D., is the Barbara Sorenson Hulka Distinguished Professor and Chair of the Department of Epidemiology of the University of North Carolina (UNC) Gillings School of Global Public Health. He is also the Associate Director of Population Sciences at the UNC Lineberger Comprehensive Cancer Center. His research interests are the etiology of cancer and reproductive, perinatal, pediatric outcomes. Recent work has focused on the role of environmental exposures, genetic factors, and adverse health effects in children and adults. He directs NIH-funded studies of head and neck cancer, breast cancer, and childhood cancer. He is director of the CDC-funded North Carolina Center for Birth Defects Research and Prevention. He has served on several National Academies committees, most recently as co-chair of the Committee to Review the Draft IRIS Assessment on Formaldehyde. He has also served as a member on four prior reviews of the health effects in Vietnam Veterans exposed to agent orange. Dr. Olshan received both is M.S. and his Ph.D. in epidemiology from the University of Washington and was a postdoctoral fellow in medical genetics at the University of British Columbia.
Dr. Nancy Berliner


Nancy Berliner, M.D., is chief of the division of hematology at Brigham and Women’s Hospital and Professor, Harvard Medical School. Her research focus is gene regulatory pathways of normal white blood cell development and how they are disrupted in leukemia and pre-leukemic syndromes as well as the pathogenesis of the anemia of aging, and benign and malignant hematologic disorders. Most recently, her laboratory has studied the role of cellular stress responses in the disruption of hematopoietic cell differentiation in myelodysplasia. A second focus of her lab is the role of inflammatory cytokines in the anemia of the elderly and in modulating the natural history of myelodysplasia. Dr. Berliner is a Member of the National Academy of Medicine (elected 2010). She received her M.D. from Yale University School of Medicine.
Dr. Wendy B. Bernstein


Wendy Bernstein, M.D., is a staff physician in oncology and hematology and chair of scientific review for the department of research programs at Walter Reed National Military Medical Center. She is also an associate professor of medicine, and an adjunct associate professor of pharmacology and of microbiology at the Uniformed Services University of the Health Sciences (USUHS). Prior to assuming these posts, Dr. Bernstein served as a staff clinician the National Cancer Institute’s Medical Oncology Branch. Her clinical practice and research activities center on hematologic and immune-mediated cancers. Dr. Bernstein is a 28-year veteran of the US Army Medical Corps, from where she retired with the rank of colonel. She received her M.D. from USUHS and is Board certified in internal medicine, oncology, and hematology.
Dr. Aravinda Chakravarti


Aravinda Chakravarti, Ph.D., is professor of medicine, pediatrics, molecular biology, and genetics, and biostatistics at the Johns Hopkins University School of Medicine and the Bloomberg School of Public Health. He has been a key participant and architect of the Human Genome, HapMap and 1000 Genomes project. His research focus is genome-scale analysis of humans and computational analysis of gene variation and function to understand the molecular genetic basis of complex human disease. Dr. Chakravarti’s discovery of genes and pathways contributing to Hirschsprung disease has served as a model for the genetic dissection of other multifactorial human disorders, such as autism spectrum disorders, hypertension, and sudden cardiac death. He was president of the American Society of Human Genetics in 2008. Dr. Chakravarti is one of the founding Editors-in-Chief of Genome Research and Annual Reviews of Genomics & Human Genetics, and serves on the boards of numerous international journals, academic societies, the NIH, and biotechnology companies. He received his Ph.D. in human genetics from the University of Texas-Houston Health Science Center. Dr. Chakravarti is a Member of the National Academy of Sciences (elected 2015) and the National Academy of Medicine (NAM; elected 2007). He is also an Honorary Fellow of the Indian Academy of Sciences. Currently he serves on the NAM Council Nominating Committee.
Dr. Lori A. White


Lori A. White, Ph.D., M.S., is an associate professor in the Department of Biochemistry and Microbiology of the School of Environmental and Biological Sciences of Rutgers, the State University of New Jersey. She received a Master’s degree in Zoology from the University of Maine, earned a Ph.D. in Biochemistry from Dartmouth Medical School, and did postdoctoral work at the University of Wisconsin. She has been active in Gordon Conference programs and was the chairperson for the Mechanisms of Toxicology summer session in 2008. Her past research focused on the elucidation of dioxin’s carcinogenic activity, specifically how TCDD activates the aryl hydrocarbon receptor pathway resulting in altered gene expression in different biologically-relevant targets. In addition to this project, her lab currently uses the zebrafish model to study the neurotoxicological and behavioral effects following exposure to environmental contaminants during development. She served on the Ninth and Tenth Biennial Updates of the Committees to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides.
Dr. Molly Kile


Molly L. Kile, Sc.D. is an associate professor in College of Public Health and Human Sciences of Oregon State University, and director of its Environmental Exposure and Biomarker Lab, and coordinates the program in Environmental & Occupational Health. She has affiliations with the university’s Center for Global Health and is a visiting scholar in the Department of Environmental Health at Harvard T.H. Chan School of Public Health. She also leads the Community Engagement Core of Oregon State University’s Superfund Basic Research Program, which works in collaboration with Native American Tribes in the Pacific Northwest to investigate their environmental health concerns and is funded by the National Institute of Environmental Health Science on a research project examining the potential for developmental exposures to influence immune functioning in children. Dr. Kile’s primary research interest is in environmental and molecular epidemiology. Her research has focused on the application of biological markers for studying exposures, and the interaction between host factors (genetic polymorphisms, nutritional status, microbiome, and epigenetic markers) and environmental exposures. She serves as an editor for the Journal of Environmental and Public Health. Dr. Kile received her Ph.D. from Harvard T.H. Chan School of Public Health in Environmental Health and continued her postdoctoral training at Harvard in molecular epidemiology.
Dr. Beate R. Ritz


Beate R. Ritz, M.D., Ph.D., M.P.H is a professor and former Chair of the Epidemiology Department at the School of Public Health at the University of California, Los Angeles (UCLA), where she has been a faculty member since 1995. Dr. Ritz holds co-appointments in both the Environmental Health department at the UCLA School of Public Health and in Neurology at the UCLA School of Medicine. She received both her M.D. and her Ph.D. in Medical Sociology from the University of Hamburg, Germany in 1987. Dr. Ritz was a research fellow and served in her residency at the Psychiatric University-Hospital in Hamburg. She went on to receive her doctoral training and a Ph.D. in Epidemiology in 1995 from UCLA. Dr. Ritz’s research has focused on environmental toxins and the health effects they may have on birth outcomes, neurodegenerative and neurodevelopmental disorders, cancers and chronic diseases. For the last two decades, she has conducted research on the effects of air pollution on adverse birth outcomes and neurodevelopmental disorders in children who live in Southern California. She also studied the long-term effects of pesticides exposure on Parkinson’s disease and cancer and is working on establishing a Parkinson’s disease registry in California. Dr. Ritz previously served on National Academies’ commitees inlcuding two committees responsible for Gulf War and Health series reports, on the Committee on the Review of the Scientific Literature on Amyotrophic Lateral Sclerosis in Veterans, and most recently Using 21st Century Science to Improve Risk-Related Evaluations.


Committee Membership Roster Comments

Drs. Kile and Ritz have been added to the committee to provide supplementary expertise in reproductive health research and epidemiology.

Events



Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Pam McCray
Contact Email:  veterans@nas.edu
Contact Phone:  -

Agenda

N/A
Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

1. Irva Hertz-Picciotto Ph.D. M.P.H. (Chair)- Present by phone
2. Nancy Berliner M.D.- Present
3. Wendy Beth Bernstein M.D.- Present
4. Michael J. Carvan III Ph.D.- Present
5. Mary A. Fox Ph.D.- Present
6. Aravinda Chakravarti Ph.D.- Present by phone
7. Karl T. Kelsey M.D.- Present
8. Dana C. Dolinoy Ph.D.- Present
9. Molly Kile Sc.D.- Present by phone
10. Andrew F. Olshan Ph.D.- Present
11. Beate R. Ritz M.D. Ph.D.- Present by phone
12. Lorie A. White Ph.D.-Present

The following topics were discussed in the closed sessions:

1. Discussion of the Conclusions and Recommendations chapter
2. Discussion of Immune Disorders, Cancers, Reproductive Outcomes and Effects on Descendants, Neurologic Disorders, Cariovascular and Circulatory Disorders and Other Chronic Outcomes chapters and their conclusions
3.Review of Introduction, Background and Evaluation of the Evidence chapters
4. Review of the Information Related to Biologic Plausibility chapter & the Epidemiologic Studies: Background on Multiply Referenced Populations chapter
5. Discussion of next steps, report sign-off/review, communication plans

Date of posting of Closed Session Summary:
May 23, 2018


Location:

Arnold and Mabel Beckman Center
100 Academy Dr.
Irvine, California
Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Pam McCray
Contact Email:  veterans@nas.edu
Contact Phone:  -

Agenda

N/A
Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

1. Irva Hertz-Picciotto Ph.D. M.P.H. (Chair)- Present both days
2. Nancy Berliner M.D.- Absent both days
3. Wendy Beth Bernstein M.D.- Present both days
4. Michael J. Carvan III Ph.D.- Present both days
5. Mary A. Fox Ph.D.- Present both days
6. Aravinda Chakravarti Ph.D.- Present by phone on both days
7. Karl T. Kelsey M.D.- Present both days
8. Dana C. Dolinoy Ph.D.- Present both days
9. Molly Kile Sc.D.- Present both days
10. Andrew F. Olshan Ph.D.- Present both days
11. Beate R. Ritz M.D. Ph.D.- Present both days
12. Lorie A. White Ph.D.-Present both days

The following topics were discussed in the closed sessions:

1. Discussed the outlines,synthesis of the evidence, and conclusions of level of association for each category
2. Reviewed any new literature available
3. Discussed concluding chapter and recommendations


Date of posting of Closed Session Summary:
April 17, 2018


Location:

Hotel Albuquerque at Old Town
800 Rio Grande Blvd. NW
Fireplace Room
Albuquerque, NM 87104

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Pam McCray
Contact Email:  veterans@nas.edu
Contact Phone:  -

Agenda

N/A
Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

1. Irva Hertz-Picciotto Ph.D. M.P.H. (Chair)- Present both days
2. Nancy Berliner M.D.- Present both days
3. Wendy Beth Bernstein M.D.- Present both days
4. Michael J. Carvan III Ph.D.- Present both days
5. Mary A. Fox Ph.D.- Present both days
6. Aravinda Chakravarti Ph.D.- Present by phone on day 1
7. Karl T. Kelsey M.D.- Present both days
8. Dana C. Dolinoy Ph.D.- Present both days
9. Molly Kile Sc.D.- Present both days
10. Andrew F. Olshan Ph.D.- Present both days
11. Beate R. Ritz M.D. Ph.D.- Present both days
12. Lorie A. White Ph.D.-Present both days

The following topics were discussed in the closed sessions:

1 - Determined what studies are primary versus secondary
2 - Justification for changing the category of association
3 - Reviewed of draft chapters and conclusions
4 - Discussed recommendations
5 - Discussed and reviewed additional literature from new search


Date of posting of Closed Session Summary:
February 22, 2018


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:   Cheri Banks
Contact Email:  veterans@nas.edu
Contact Phone:  -

Agenda

REVIEW OF THE HEALTH EFFECTS IN VIETNAM VETERANS OF EXPOSURE TO HERBICIDES: ELEVENTH BIENNIAL UPDATE public meeting
November 30, 2017

Keck Center of the National Academies; 500 Fifth Street, NW; Washington, DC 20001
Room 103 and via webcast

10:15–10:30 am
Welcome | Notes on the conduct of the open session | Introduction of participants
Irva Hertz-Piccioto, PhD, Committee Chair

10:30–11:15 am – Effects on descendants presentation
Thaddeus (Thad) Schug, PhD
Health Scientist Administrator, Population Health Branch, National Institute of Environmental Health Sciences and the National Toxicology Program

11:15–noon – Effects on descendants presentation
Russ Hauser, ScD
Frederick Lee Hisaw Professor of Reproductive Physiology. Chair, Department of Environmental Health, Harvard TH Chan School of Public Health

noon–12:45 pm
break

12:45–1:30 pm – Multiple myeloma and MGUS presentation
C. Ola Landgren, MD, PhD
Professor of Medicine and Chief Attending Physician of the Myeloma Service, Memorial Sloan Kettering Cancer Center

1:30–2:15 pm – Glioblastoma presentation
Quinn T. Ostrom, PhD, MPH
Research Coordinator, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine; Research Manager and Primary Analyst, Central Brain Tumor Registry of the United States

2:15–3:00 pm – Glioblastoma presentation
Paul S. Mischel, MD
Member and Head, Laboratory of Molecular Pathology, Ludwig Institute for Cancer Research San Diego and Professor, Department of Pathology, University of California, San Diego

3:00–3:30 pm – US Department of Veterans Affairs presentation
Ralph L Erickson, MD, DrPH
Chief Consultant, Post-Deployment Health Services
Peter D. Rumm, MD, MPH
Director, Pre-9/11 Era Environmental Health Program,PDHS

3:30–4:00 pm
public comments (spoken comments may not exceed three minutes per person; written submissions of any length are welcome)

4:00 pm
open session adjourns

[order of speakers subject to change]
Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

1. Irva Hertz-Picciotto Ph.D. M.P.H. (Chair)- Present both days
2. Nancy Berliner M.D.- Present both days
3. Wendy Beth Bernstein M.D.- Present both days
4. Michael J. Carvan III Ph.D.- Present both days
5. Mary A. Fox Ph.D.- Present both days
6. Aravinda Chakravarti Ph.D.- Present both days
7. Karl T. Kelsey M.D.- Present the first day
8. Dana C. Dolinoy Ph.D.- Present both days
9. Molly Kile Sc.D.- Present both days
10. Andrew F. Olshan Ph.D.- Present in-person day 1 and by phone day 2
11. Beate R. Ritz M.D. Ph.D.- Present both days
12. Lorie A. White Ph.D.-Present both days

The following topics were discussed in the closed sessions:

Discussed new published studies on health outcomes from the exposures of interest including cancers, effects on descendants, reproductive outcomes, neurologic diseases, and cardiovascular and blood disorders
Discussed invited presentations on transgenerational and multigenerational effects on descendants, glioblastoma multiforme, and multiple myeloma
Continued planning for the next few months of the study

Date of posting of Closed Session Summary:
December 04, 2017


Location:

Courtyard Marriott Bloomington by Mall of America

7800 Bloomington Avenue S.
Lake Hiawatha Room
Bloomington, MN 55425

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Pam McCray
Contact Email:  veterans@nas.edu
Contact Phone:  -

Agenda

REVIEW OF THE HEALTH EFFECTS IN VIETNAM VETERANS OF EXPOSURE TO HERBICIDES: ELEVENTH BIENNIAL UPDATE
September 7, 2017, Meeting 3

Lake Hiawatha Room

1:00–1:10 pm Welcome | Notes on the conduct of the open session | Introduction of participants
Irva Hertz-Picciotto, PhD
Committee Chair

1:10–2:30 pm presentations by participants and questions from the Committee

2:30 OPEN SESSION-ENDS
Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

1. Irva Hertz-Picciotto Ph.D. M.P.H. (Chair)- Present both days
2. Nancy Berliner M.D.- Present both days
3. Wendy Beth Bernstein M.D.- Present both days
4. Michael J. Carvan III Ph.D.- Present both days
5. Mary A. Fox Ph.D.- Present both days
6. Aravinda Chakravarti Ph.D.- Present both days
7. Karl T. Kelsey M.D.- Present the first day
8. Dana C. Dolinoy Ph.D.- Present both days
9. Molly Kile Sc.D.- Present both days
10. Andrew F. Olshan Ph.D.- Present both days
11. Beate R. Ritz M.D. Ph.D.- Present both days
12. Lorie A. White Ph.D.-Present both days

The following topics were discussed in the closed sessions:

Discussed meeting objectives
Reviewed statement of task
Reviewed epidemiologic and toxicologic literature for the following sections (Cancer, kidney-urinary, skin disorders, respiratory conditions, reproductive conditions, diabetes and endocrine disorders)
Reviewed written drafts for the report (for the mentioned sections above)
Discussed strategy for reviewing literature and writing drafts for the remaining outcomes (effects on descendants, cardiovascular and blood disorders, immune system disorders, neurologic disorders, other outcomes)
Planned for the next few months of the study (study timeline, initial planning for meeting 4 and expectations for meeting 4)






Date of posting of Closed Session Summary:
September 11, 2017


Location:

The Faculty Club
Lewis-Latimer Room
UC, Berkeley
Berkeley, CA 94704
Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Pam McCray
Contact Email:  veterans@nas.edu
Contact Phone:  -

Agenda

N/A
Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

1. Irva Hertz-Picciotto Ph.D. M.P.H. (Chair)- Present day 1 & day 2
2. Nancy Berliner M.D.- Present on day 1. Absent on day 2
3. Wendy Beth Bernstein M.D.- Present day 1 & day 2
4. Michael J. Carvan III Ph.D.- Present day 1 & 2
5. Mary A. Fox Ph.D.- Present day 1 & day 2 by phone
7. Karl T. Kelsey M.D.- Present day 1 & day 2
8. Dana C. Dolinoy Ph.D.- Present day 1. Absent on day 2
9. Molly Kile Sc.D.- Present day 1 & 2
10. Andrew F. Olshan Ph.D.- Present day 1 & day 2 by phone
11. Beate R. Ritz M.D. Ph.D.- Present day 1 & day 2
12. Lorie A. White Ph.D.-Present day 1 & day 2


The following topics were discussed in the closed sessions:

1. Determined what constitutes sufficient evidence and limited or suggestive evidence based upon past committee decisions
2. Reviewed literature search strategy and inclusion/exclusion criteria for studies
3. Reviewed list of outcomes to be evaluated by committee
4. Discussed what the report outline should look like
5. Discussed statement of task-specific outcomes and effects
6. Planned a study timeline and initial planning for meeting 3 and 4


Date of posting of Closed Session Summary:
May 22, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Pam McCray
Contact Email:  veterans@nas.edu
Contact Phone:  -

Agenda

REVIEW OF THE HEALTH EFFECTS IN VIETNAM VETERANS OF EXPOSURE TO HERBICIDES: ELEVENTH BIENNIAL UPDATE
March 2, 2017, Meeting 1

Keck Center, 500 Fifth St., NW, Washington, DC
Room 103

1:00–1:10 PM
Welcome and Introductions
Irva Hertz-Picciotto, PhD, Committee Chair

1:10–2:00
Charge to the Committee and discussion
Peter R. Rumm, MD, MPH
Director, Pre-9/11 Era Environmental Health Program, Department of Veterans Affairs
R. Loren Erickson, MD, DrPH
Chief Consultant, Post Deployment Health

2:00–2:45
Overview of VA’s Vietnam Era Health Retrospective Observational Study (HEROeS)
Victoria Davey, PhD, MPH, RN
Principal Investigator, VA

2:45–3:30
VA Health Care Utilization for Vietnam Veterans
Aaron I. Schneiderman, PhD, MPH, RN
Director, Epidemiology Program, Post-Deployment Health Services, VA

3:30–4:30
Open microphone for public comments (Limited to 5 minutes per individual/organization)

4:30
Open Session Ends
Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

1. Irva Hertz-Picciotto Ph.D. M.P.H. (Chair)- Present day 1 & day 2
2. Nancy Berliner M.D.- Present by phone on day 1 for the bias discussion
3. Wendy Beth Bernstein M.D.- Present day 1 & day 2
4. Michael J. Carvan III Ph.D.- Present day 1 by phone
5. Mary A. Fox Ph.D.- Present day 1 & day 2
6. Aravinda Chakravarti Ph.D.- Present day 1 & day 2
7. Karl T. Kelsey M.D.- Present day 1 & day 2 by phone
8. Dana C. Dolinoy Ph.D.- Present day 1 & day 2
9. Molly Kile Sc.D.- Present by phone day 1 & day 2
10. Andrew F. Olshan Ph.D.- Present day 1 & day 2
11. Beate R. Ritz M.D. Ph.D.- Present day 1 & day 2
12. Lorie A. White Ph.D.-Present day 1 & day 2

The following topics were discussed in the closed sessions:

Intro of all committee members and staff
Reviewed meeting objectives
Held bias and conflict of interest discussion
Reviewed committee process and expectations (goals and timelines for the project)
Discussed the statement of task
Conduct of the open session
Discussed the literature search terms from previous update and changes for current study
Discussed the approach, general report outline, additional data and information needs

The following materials (written documents) were made available to the committee in the closed sessions:

N/A

Date of posting of Closed Session Summary:
March 07, 2017

Publications

  • Publications having no URL can be seen at the Public Access Records Office
Publications

No data present.